Published in BMJ on December 03, 1988
Serum screening for Down's syndrome: some women's experiences. BMJ (1993) 4.29
The new genetics. Psychological responses to genetic testing. BMJ (1998) 2.71
Experiences of patients with false positive results from colorectal cancer screening. Br J Gen Pract (1990) 1.13
Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy. West J Med (2000) 0.98
Long-term symptoms of depression and anxiety in mothers of infants with congenital heart defects. J Pediatr Psychol (2010) 0.92
Interventions for reducing anxiety in women undergoing colposcopy. Cochrane Database Syst Rev (2011) 0.83
Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study. Fam Cancer (2009) 0.80
Trajectories of maternal mental health: a prospective study of mothers of infants with congenital heart defects from pregnancy to 36 months postpartum. J Pediatr Psychol (2012) 0.80
Levels of state and trait anxiety in patients referred to ophthalmology by primary care clinicians: a cross sectional study. PLoS One (2013) 0.76
Anxiety during a crisis: emotional effects of screening for neural tube defects. J Psychosom Res (1984) 3.20
A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature (2000) 47.15
Life with 6000 genes. Science (1996) 41.51
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25
Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1984) 20.61
Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care (2005) 12.73
Complete genome sequence of Methanobacterium thermoautotrophicum deltaH: functional analysis and comparative genomics. J Bacteriol (1997) 12.21
The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet (2002) 10.52
A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiol Rev (1987) 7.00
Internists' attitudes about clinical practice guidelines. Ann Intern Med (1994) 6.55
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
Will genetics revolutionize medicine? N Engl J Med (2000) 5.41
Presenting a routine screening test in antenatal care: practice observed. Public Health (1992) 5.34
COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc Natl Acad Sci U S A (2001) 5.19
Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet (1969) 5.13
Inability of trained nurses to perform basic life support. Br Med J (Clin Res Ed) (1987) 5.08
Green fluorescent protein as a marker for gene expression and subcellular localization in budding yeast. Yeast (1996) 4.53
A measure of informed choice. Health Expect (2001) 4.52
Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med (1997) 4.47
Paramedics and technicians are equally successful at managing cardiac arrest outside hospital. BMJ (1995) 4.47
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg (1997) 4.47
Sensory extinction and sensory reinforcement principles for programming multiple adaptive behavior change. J Appl Behav Anal (1979) 4.27
Surveying Saccharomyces genomes to identify functional elements by comparative DNA sequence analysis. Genome Res (2001) 4.22
Function and regulation of yeast hexose transporters. Microbiol Mol Biol Rev (1999) 3.96
Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods. Int J Obes Relat Metab Disord (2000) 3.90
Three different regulatory mechanisms enable yeast hexose transporter (HXT) genes to be induced by different levels of glucose. Mol Cell Biol (1995) 3.74
Two glucose transporters in Saccharomyces cerevisiae are glucose sensors that generate a signal for induction of gene expression. Proc Natl Acad Sci U S A (1996) 3.54
Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science (1991) 3.41
Disability: a model and measurement technique. Br J Prev Soc Med (1976) 3.41
Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis. Clin Oncol (R Coll Radiol) (2002) 3.33
Application of operant conditioning procedures to the behavior problems of an autistic child: a follow-up and extension. Behav Res Ther (1967) 3.23
Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency. J Exp Med (1980) 3.13
Regulated expression of the GAL4 activator gene in yeast provides a sensitive genetic switch for glucose repression. Proc Natl Acad Sci U S A (1991) 3.00
Grr1 of Saccharomyces cerevisiae is connected to the ubiquitin proteolysis machinery through Skp1: coupling glucose sensing to gene expression and the cell cycle. EMBO J (1997) 2.97
Regulated nuclear translocation of the Mig1 glucose repressor. Mol Biol Cell (1997) 2.96
Glucose sensing and signaling by two glucose receptors in the yeast Saccharomyces cerevisiae. EMBO J (1998) 2.96
The increased risk of death from ischaemic heart disease in first degree relatives of 121 men and 96 women with ischaemic heart disease. J Med Genet (1966) 2.89
Informed decision making: an annotated bibliography and systematic review. Health Technol Assess (1999) 2.74
Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol (1990) 2.74
Genetic evidence that zinc is an essential co-factor in the DNA binding domain of GAL4 protein. Nature (1987) 2.71
Development of the human coagulation system in the full-term infant. Blood (1987) 2.69
An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration. Soc Sci Med (1987) 2.69
Two systems of glucose repression of the GAL1 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1990) 2.65
Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. BMJ (1994) 2.65
Psychological impact of predicting individuals' risks of illness: a systematic review. Soc Sci Med (1999) 2.63
Cloning, nucleotide sequence, and expression of the Bacillus cereus 5/B/6 beta-lactamase II structural gene. J Bacteriol (1988) 2.55
Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med (2001) 2.35
GRR1 of Saccharomyces cerevisiae is required for glucose repression and encodes a protein with leucine-rich repeats. Mol Cell Biol (1991) 2.34
Changing clinicians' behavior: a randomized controlled trial of fees and education. J Dent Res (2008) 2.34
Identification of the cystic fibrosis gene. BMJ (1990) 2.34
Establishing a therapeutic range for heparin therapy. Ann Intern Med (1993) 2.31
The work of a clinical psychologist in primary care. J R Coll Gen Pract (1978) 2.31
Characterization of three related glucose repressors and genes they regulate in Saccharomyces cerevisiae. Genetics (1998) 2.27
The impact of communications about swine flu (influenza A H1N1v) on public responses to the outbreak: results from 36 national telephone surveys in the UK. Health Technol Assess (2010) 2.23
Baseline staging tests in primary breast cancer: a practice guideline. CMAJ (2001) 2.22
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost (2004) 2.21
Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet (2000) 2.18
Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. BMJ (1990) 2.17
tRNA genes as transcriptional repressor elements. Mol Cell Biol (1994) 2.10
Predictors of emotional outcomes of intensive care. Anaesthesia (2005) 2.10
The impact of prenatal screening and diagnostic testing upon the cognitions, emotions and behaviour of pregnant women. J Psychosom Res (1989) 2.06
Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. BMJ (1995) 2.06
Galactose as a gratuitous inducer of GAL gene expression in yeasts growing on glucose. Gene (1989) 2.04
Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04
Teaching communication skills to clinical students. BMJ (1993) 2.02
Identification of native complexes containing the yeast coactivator/repressor proteins NGG1/ADA3 and ADA2. J Biol Chem (1997) 1.98
Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology (1991) 1.97
Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J Med Genet (2007) 1.97
Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet (1972) 1.95
Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med (1999) 1.94
Two zinc-finger-containing repressors are responsible for glucose repression of SUC2 expression. Mol Cell Biol (1996) 1.92
Evidence for different interleukin 1 receptors in murine B- and T-cell lines. Proc Natl Acad Sci U S A (1989) 1.90
Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. Lancet (2001) 1.90
Maturation of the hemostatic system during childhood. Blood (1992) 1.89
The nuclear exportin Msn5 is required for nuclear export of the Mig1 glucose repressor of Saccharomyces cerevisiae. Curr Biol (1999) 1.89
Genetic epidemiology of breast cancer in Britain. Ann Hum Genet (1991) 1.89
Psychological consequences of screening for Down's syndrome. BMJ (1993) 1.87
The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab (1997) 1.87
Mutations that inactivate a yeast transcriptional regulatory protein cluster in an evolutionarily conserved DNA binding domain. Proc Natl Acad Sci U S A (1987) 1.86
Rgt1p of Saccharomyces cerevisiae, a key regulator of glucose-induced genes, is both an activator and a repressor of transcription. Mol Cell Biol (1996) 1.85
Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Soc Sci Med (1999) 1.83
cDNA-derived amino acid sequence of the 86-kDa subunit of the Ku antigen. J Biol Chem (1989) 1.81
Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group. Lancet (1996) 1.79
Coning and lumbar puncture. Lancet (1980) 1.78
Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol (1990) 1.78
Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ (1999) 1.76
Medical ethics: a survey of general practitioners' attitudes. J R Coll Gen Pract (1983) 1.74
Educational package on hypertension for primary care physicians. Can Med Assoc J (1984) 1.73
Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol (1995) 1.71
Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol. Br Med J (1977) 1.71
Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer. CMAJ (2001) 1.71
Inherited disorders associated with colorectal cancer. Cancer Surv (1989) 1.70
Impacts of soil faunal community composition on model grassland ecosystems. Science (2002) 1.70